Analytical Framework for Examining the Value of Antibacterial Products. A.2.3 List of Drugs Used in Determining Different Market Size Estimates

04/15/2014

Appendix Table 2: List of Drugs Used in Determining Different Market Size Estimates for ABSSSI

Market Size Estimate 1 Market Size Estimate 2 Market Size Estimate 3
AMPICILLIN/SULBACTAM (IV) CEFACLOR (oral) AMIKACIN (IV)
AZTREONAM (IV) CEFADROXIL (oral) AMOXICILLIN (oral)
CEFAZOLIN (IV) CEFDINIR (oral) AMOXICILLIN/CLAVULANIC ACID (oral)
CEFEPIME (IV) CEFDITOREN PIVOXIL (oral) AMPICILLIN (IV)
CEFOTAXIME (IV) CEFPODOXIME PROXETIL (oral) AMPICILLIN (oral)
CEFOTETAN (IV) CEFPROZIL (oral) AZITHROMYCIN (IV)
CEFOXITIN (IV) CEFUROXIME AXETIL (oral) AZITHROMYCIN (oral)
CEFTAROLINE FOSAMIL (IV) CEPHALEXIN (oral) CLARITHROMYCIN (oral)
CEFTAZIDIME (IV) CIPROFLOXACIN (oral) COLISTIN (IV)
CEFTIZOXIME (IV) CLINDAMYCIN (oral) ERYTHROMYCIN (IV)
CEFTRIAXONE (IV) DOXYCYCLINE (oral) ERYTHROMYCIN (oral)
CEFUROXIME (IV) LEVOFLOXACIN (oral) GEMIFLOXACIN (oral)
CHLORAMPHENICOL (IV) LINEZOLID (oral) GENTAMICIN (IV)
CIPROFLOXACIN (IV) METRONIDAZOLE (oral) LOMEFLOXACIN (oral)
CLINDAMYCIN (IV) MOXIFLOXACIN (oral) MINOCYCLINE (IV)
DAPTOMYCIN (IV) OFLOXACIN (oral) MINOCYCLINE (oral)
DOXYCYCLINE (IV) PENICILLIN G (oral) NORFLOXACIN (oral)
ERTAPENEM (IV) SULFAMETHOXAZOLE/TRIMETHOPRIM (oral) PIPERACILLIN (IV)
IMIPENEM/CILASTATIN (IV) VANCOMYCIN (oral) TELITHROMYCIN (oral)
LEVOFLOXACIN (IV)   TETRACYCLINE (oral)
LINEZOLID (IV)   TOBRAMYCIN (IV)
MEROPENEM (IV)    
METRONIDAZOLE (IV)    
MOXIFLOXACIN (IV)    
NAFCILLIN (IV)    
OXACILLIN (IV)    
PENICILLIN G (IV)    
PIPERACILLIN/TAZOBACTAM (IV)    
QUINUPRISTIN/DALFOPRISTIN (IV)    
SULFAMETHOXAZOLE/TRIMETHOPRIM (IV)    
TELAVANCIN (IV)    
TICARCILLIN/CLAVULANIC ACID (IV)    
TIGECYCLINE (IV)    
VANCOMYCIN (IV)    

 

View full report

Preview
Download

"rpt_antibacterials.pdf" (pdf, 1.43Mb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®